Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-26

Clinical Trial Update: Resiliency Training in Adolescents With NF1 and NF2 [NA]

View source ↗

Summary

Clinical trial update describing resiliency training for adolescents with neurofibromatosis types 1 and 2; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Neurofibromatoses | NA | Status: ACTIVE_NOT_RECRUITING